Press Releases

AUSTIN, Texas, Dec. 12, 2019 /PRNewswire/ -- The Riveter, a modern day union of women and allies providing community, content, resources, and work and gathering spaces, has partnered with

SCOTTSDALE, Ariz., Dec. 12, 2019 /PRNewswire/ -- Assisted Living Locators, a nationwide senior placement and referral franchise, has been ranked among the Top 100 Game Changers by Franchise Dictionary Magazine for the second straight year.

DENVER, Dec. 12, 2019 /PRNewswire/ -- After calls by advocacy groups to designate

- PROMIS study findings presented today at SABCS 2019 - IRVINE, Calif. and AMSTERDAM, Dec. 12, 2019 /PRNewswire/ -- Agendia, Inc., a worl

-  MDNA55 achieves up to 5 fold increase in 12 month survival rate in aggressive, chemotherapy resistant glioblastoma when compared to approved therapies TORONTO and HOUSTON, Dec. 12, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF),

BOSTON, Dec. 12, 2019 /PRNewswire/ -- Well-established medical guidelines recommend biomarker testing for all patients with metastatic colon cancer, but new research shows this may not be consistent with actual patterns of care. COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, recently collaborated on a stu

TYSONS, Va., Dec. 12, 2019 /PRNewswire/ -- CNSI, a leading business solutions provider in developing and delivering innovative health information technology solutions, announced today that veteran operations executive

SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy solutions, today announced that on December 11, 2019 it closed its previously announced underwritten public offering of 24,600,000 shares of its common stock (or pre-funded warrants to purcha

SAN DIEGO and SHAOXING, China, Dec. 12, 2019 /PRNewswire/ -- Zhejiang Medicine, NovoCodex and Ambrx announced positive interim topline data from the ongoing "111" trial (CTR20171162) evaluating ARX788, a novel anti-HER2 ADC, in heavily pretreated patients with metastatic HER2 positive breast cancer. All patients enrolled had failed p

HOUSTON, Dec. 12, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, followed a strong appearance at the annual meeting of the Radiological Society of North America (RSNA) with a win in a competition jointly organized by Facebook AI Research and NYU Langone Health. The